Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1993;87:909-920

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, J.
Right arrow Articles by Ferrans, V. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, J.
Right arrow Articles by Ferrans, V. J.

Circulation, Vol 87, 909-920, Copyright © 1993 by American Heart Association


ARTICLES

Interstitial dendritic cells of the rat heart. Quantitative and ultrastructural changes in experimental myocardial infarction

J Zhang, ZX Yu, S Fujita, ML Yamaguchi and VJ Ferrans
Ultrastructure Section, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md 20892.

BACKGROUND. This study was undertaken to investigate the qualitative and quantitative changes that interstitial dendritic cells (IDC) of the heart undergo during the time course of experimental myocardial infarction. METHODS AND RESULTS. Left coronary arterial ligations were performed in 43 rats that were killed 2, 4, 7, 14, and 21 days after surgery. Thirteen unoperated and 39 sham-operated rats were used as controls. Frozen sections were stained with monoclonal antibodies (OX 6 and W3/25) to identify and count IDC by light microscopy. Immunoelectron microscopy was also used to identify IDC. The number of IDC per mm2 of tissue section was calculated for all hearts. In hearts with myocardial infarction, IDC were counted in three areas: the center of the myocardial infarction, the border zone, and the noninfarcted left ventricle. In OX 6 antibody-stained preparations, the number of IDC per mm2 was 82 +/- 10 in the left ventricle of unoperated rats. Hearts with myocardial infarction showed marked increases in the numbers of IDC per mm2 in the border zone (796 +/- 79 at 7 days and 528 +/- 98 at 14 days). In the border zone, IDC often were associated with small clusters of T-helper lymphocytes, which reacted with W3/25 antibody (the rat homologue of human CD4). The center of the myocardial infarction showed an increase in IDC only on day 7 (120 +/- 18). By 21 days, IDC in the border zone were only slightly increased (159 +/- 15). CONCLUSIONS. These findings suggest that IDC migrate to the myocardial infarction border zone. They participate in the activation of lymphocytes and in the initiation of immune responses and decrease in number as inflammation subsides and scarring develops.


This article has been cited by other articles:


Home page
CirculationHome page
Y. Maekawa, N. Mizue, A. Chan, Y. Shi, Y. Liu, S. Dawood, M. Chen, F. Dawood, G. de Couto, G. H. Li, et al.
Survival and Cardiac Remodeling After Myocardial Infarction Are Critically Dependent on the Host Innate Immune Interleukin-1 Receptor-Associated Kinase-4 Signaling: A Regulator of Bone Marrow-Derived Dendritic Cells
Circulation, October 6, 2009; 120(14): 1401 - 1414.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
Y. Mori, T. Izawa, S. Takenaka, M. Kuwamura, and J. Yamate
Participation of Functionally Different Macrophage Populations and Monocyte Chemoattractant Protein-1 in Early Stages of Thioacetamide-induced Rat Hepatic Injury
Toxicol Pathol, June 1, 2009; 37(4): 463 - 473.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Naito, T. Anzai, Y. Sugano, Y. Maekawa, T. Kohno, T. Yoshikawa, K. Matsuno, and S. Ogawa
Differential Effects of GM-CSF and G-CSF on Infiltration of Dendritic Cells during Early Left Ventricular Remodeling after Myocardial Infarction
J. Immunol., October 15, 2008; 181(8): 5691 - 5701.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Takahashi, S. Fukushima, K. Yamahara, K. Yashiro, Y. Shintani, S. R. Coppen, H. K. Salem, S. W. Brouilette, M. H. Yacoub, and K. Suzuki
Modulated Inflammation by Injection of High-Mobility Group Box 1 Recovers Post-Infarction Chronically Failing Heart
Circulation, September 30, 2008; 118(14_suppl_1): S106 - S114.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
J. Yamate, Y. Machida, M. Ide, M. Kuwamura, T. Kotani, O. Sawamoto, and J. LaMarre
Cisplatin-Induced Renal Interstitial Fibrosis in Neonatal Rats, Developing as Solitary Nephron Unit Lesions
Toxicol Pathol, February 1, 2005; 33(2): 207 - 217.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
J. Yamate, K. Sato, M. Ide, M. Nakanishi, M. Kuwamura, S. Sakuma, and S. Nakatsuji
Participation of Different Macrophage Populations and Myofibroblastic Cells in Chronically Developed Renal Interstitial Fibrosis after Cisplatin-induced Renal Injury in Rats
Vet. Pathol., May 1, 2002; 39(3): 322 - 333.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. V. Tjurmin, N. M. Ananyeva, E. P. Smith, Y. Gao, M. K. Hong, M. B. Leon, and C. C. Haudenschild
Studies on the Histogenesis of Myxomatous Tissue of Human Coronary Lesions
Arterioscler Thromb Vasc Biol, January 1, 1999; 19(1): 83 - 97.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
J. Yamate, A. Okado, M. Kuwamura, Y. Tsukamoto, F. Ohashi, Y. Kiso, S. Nakatsuji, T. Kotani, S. Sakuma, and J. Lamarre
Immunohistochemical Analysis of Macrophages, Myofibroblasts, and Transforming Growth Factor-{beta} Localization during Rat Renal Interstitial Fibrosis Following Long-Term Unilateral Ureteral Obstruction
Toxicol Pathol, November 1, 1998; 26(6): 793 - 801.
[Abstract] [PDF]


Home page
Toxicol PatholHome page
Jun Zhang, R. J. Wenthold JR., Z.-X. Yu, E. H. Herman, and V. J. Ferrans
Characterization of the Pulmonary Lesions Induced in Rats by Human Recombinant Interleukin-2
Toxicol Pathol, November 1, 1995; 23(6): 653 - 666.
[Abstract] [PDF]